In vitro activity of clarithromycin and its 14-hydroxy-metabolite against 203 strains ofHaemophilus influenzae
Author:
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF01704612.pdf
Reference17 articles.
1. Hardy, D. J., Guay, D. R. P., Jones, R. N. Clarithromycin, a unique macrolide: a pharmacokinetic, microbiologic and clinical overview. Diagn. Microbiol. Infect. Dis. 15 (1992) 39–53.
2. Floyd-Reising, S., Hindler, J. A., Young, L. S. In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of eryhtromycin and other antimicrobial agents. Antimicrob. Agents Chemother. 31 (1987) 640–642.
3. Fernandes, P. B., Hardy, D., Bailer, R., McDonald, E., Pintar, J., Ramer, N., Swanson, R., Gade, E. Susceptibility testing of macrolide antibiotics againstHaemophilus influenzae and correlation ofin vitro results within vivo efficacy in a mouse septicemia model. Antimicrob. Agents Chemother. 31 (1987) 1243–1250.
4. Hardy, D. J., Swanson, R. N., Rode, R. A., Marsh, K., Shipkowitz, N. A., Clement, J. J. Enhancement of thein vitro andin vivo activities of clarithromycin againstHaemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. Antimicrob. Agents Chemother. 34 (1990) 1407–1413.
5. Dabernat, H., Delmas, C., Seguy, M., Fourtillan, J. B., Girault, Lareng M. B. The activity of clarithromycin and its 14-hydroxymetabolite againstHaemophilus influenzae, determined byin vitro and serum bactericidal tests. J. Antimicrob. Chemother. 27 (Suppl. A) (1991) 19–30.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug Design Strategies: Role of Structural Modifications of Drug Candidates to Improve PK Parameters of New Drugs;Drug Metabolism Handbook;2022-11-18
2. In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections;Infection and Drug Resistance;2019-03
In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections
3. Macrolides;Textbook of Critical Care;2011
4. Improving Drug Design: Considerations for the Structural Modification Process;Biotransformation and Metabolite Elucidation of Xenobiotics;2010-09-07
5. Structural Modifications of Drug Candidates: How Useful Are They in Improving PK Parameters of New Drugs? Part II: Drug Design Strategies;Pharmaceutical Sciences Encyclopedia;2010-03-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3